Article
A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients.
Molecular immunology - 1 Oct 2017
Ben-Khemis Leila, Mekki Najla, Ben-Mustapha Imen, Rouault Karen, Mellouli Fethi, Khemiri Monia, Bejaoui Mohamed, Essaddam Leila, Ben-Becher Saayda, Boughamoura Lamia, Hassayoun Saida, Ben-Ali Meriem, Barbouche Mohamed-Ridha
Abstract excerpt
Phosphoglucomutase 3 (PGM3) protein catalyzes the conversion of N-acetyl-d-glucosamine-6-phosphate (GlcNAc-6-P) to N-acetyl-d-glucosamine-1-phosphate (GlcNAc-1-P), which is required for the synthesis of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) an important precursor for protein glycosylation. Mutations in PGM3 gene have been recently shown to underlie a new congenital disorder of glycosylation often...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
